Yasin Keshvargar

Davis Polk advised the lead book-running manager and representative of the underwriters in connection with its $101.9 million initial public offering of common stock of Jounce Therapeutics,…

Davis Polk advised the representatives of the underwriters in connection with the SEC-registered offering of 40,000,000 shares of common stock of Callon Petroleum Company. The shares are…

Davis Polk advised the joint book-running managers in connection with the offering of 4,000,000 shares of Class A common stock of Genesee & Wyoming Inc. The net proceeds from the Class…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Evolent Health, Inc. of $125 million aggregate principal amount of its 2.00% senior convertible notes…

Davis Polk advised the representative of the several underwriters in connection with an SEC-registered secondary offering of 1,568,000 shares of Veritiv Corporation’s common stock by UWW…

Davis Polk advised Banco de Bogotá S.A. in connection with a reopening of $500 million aggregate principal amount of its 6.250% subordinated notes due 2026, pursuant to Rule 144A and…

Davis Polk advised Advanced Accelerator Applications S.A. on its approximately $150 million SEC-registered follow-on offering of American Depositary Shares representing its ordinary shares…

Davis Polk advised the initial purchasers in connection with a Rule 144A/Regulation S offering of $400 million aggregate principal amount of Callon Petroleum Company’s 6.125% senior…

Davis Polk advised the representatives of the several underwriters, in connection with a secondary offering of 7,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of…

Davis Polk advised the representatives of the underwriters in connection with the SEC-registered offering of 29,900,000 shares of common stock of Callon Petroleum Company (“Callon”). The…